Contribution of nonesterified fatty acids to insulin resistance in the elderly with normal fasting but diabetic 2-hour postchallenge plasma glucose levels: the Baltimore Longitudinal Study of Aging

Metabolism: Clinical and Experimental

Volumn 56, Issue 10, 2007, Pages 1444-1451

  Carlson, Olga D ^a   David, Jehan D ^a   Schrieder, Jessica M ^a   Muller, Dennis C ^a   Jang, Hyeung Jin ^a   Kim, Byung Joon ^a   Egan, Josephine M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

AGED; AGING; ARTICLE; CLINICAL ARTICLE; CYTOKINE RELEASE; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOLYSIS; LONGITUDINAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; AGED, 80 AND OVER; AGING; BALTIMORE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HORMONES; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; MARYLAND;

EID: 34548646616     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.06.009     Document Type: Article

References (45)

1. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
2. Erlinger T.P., and Brancati F.L. Postchallenge hyperglycemia in a national sample of US adults with type 2 diabetes. Diabetes Care 24 (2001) 1734-1738
3. Hosseinpanah F., Rambod M., Reza Ghaffari H.R., et al. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabet Med 23 (2006) 982-989
4. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care 22 (1999) 1667-1671
5. Saydah S.H., Miret M., Sung J., et al. Postchallenge hyperglycemia and mortality in a national sample of US adults. Diabetes Care 24 (2001) 1397-1402
6. Barrett-Connor E., and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study. Diabetes Care 21 (1998) 1236-1239
7. Shaw J.E., Hodge A.M., de Courten M., et al. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42 (1999) 1050-1054
8. Blake D.R., Meigs J.B., Muller D.C., et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53 (2004) 2095-2100
9. van Haeften T.W., Pimenta W., Mitrakou A., et al. Relative contributions of beta-cell function and tissue insulin sensitivity to fasting and post-glucose-load glycemia. Metabolism 49 (2000) 1318-1325
10. Meyer C., Dostou J.M., Welle S.L., et al. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab 282 (2002) E419-E427
11. NW GR, Shock, R. Andres, Normal human aging: the Baltimore Longitudinal Study of Aging. Baltimore, MD, US Department of Health and Human Services, Public Health Service, National Institutes of Health, Institute on Aging, Gerontology Research Center, Baltimore City Hospitals, Baltimore, MD.
12. Theodorakis M.J., Carlson O., Muller D.C., et al. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 27 (2004) 1692-1698
13. Kim B.J., Carlson O.D., Jang H.J., et al. Peptide YY is secreted after oral glucose administration in a gender-specific manner. J Clin Endocrinol Metab 90 (2005) 6665-6671
14. Shimokata H., Tobin J.D., Muller D.C., et al. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 44 (1989) M66-M73
15. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
16. Bruce D.G., Chisholm D.J., Storlien L.H., et al. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 37 (1988) 736-744
17. Theodorakis M.J., Muller D.C., Carlson O., et al. Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose. Metabolism 52 (2003) 1523-1524 [discussion 4-5]
18. Stumvoll M., Mitrakou A., Pimenta W., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
19. Stumvoll M., Van Haeften T., Fritsche A., et al. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24 (2001) 796-797
20. Kanauchi M., Yamano S., Kanauchi K., et al. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 88 (2003) 3444-3446
21. Large V., Peroni O., Letexier D., et al. Metabolism of lipids in human white adipocyte. Diabetes Metab 30 (2004) 294-309
22. Stumvoll M., and Jacob S. Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes 107 (1999) 107-110
23. Vaag A., Alford F., Henriksen F.L., et al. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38 (1995) 326-336
24. Dresner A., Laurent D., Marcucci M., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103 (1999) 253-259
25. Lam T.K., van de Werve G., and Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284 (2003) E281-E290
26. Staehr P., Hother-Nielsen O., Landau B.R., et al. Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes 52 (2003) 260-267
27. Santomauro A.T., Boden G., Silva M.E., et al. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48 (1999) 1836-1841
28. Langin D. Diabetes, insulin secretion, and the pancreatic beta-cell mitochondrion. N Engl J Med 345 (2001) 1772-1774
29. Eldor R., and Raz I. Lipotoxicity versus adipotoxicity-the deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes. Diabetes Res Clin Pract 74 (2006) 53-58
30. Petersen K.F., Oral E.A., Dufour S., et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109 (2002) 1345-1350
31. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
32. Silha J.V., Krsek M., Skrha J., et al. Plasma resistin, leptin and adiponectin levels in non-diabetic and diabetic obese subjects. Diabet Med 21 (2004) 497-499
33. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
34. Stefan N., Bunt J.C., Salbe A.D., et al. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 87 (2002) 4652-4656
35. Curat C.A., Wegner V., Sengenes C., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49 (2006) 744-747
36. Heilbronn L.K., Rood J., Janderova L., et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89 (2004) 1844-1848
37. Kusminski C.M., McTernan P.G., and Kumar S. Role of resistin in obesity, insulin resistance and type II diabetes. Clin Sci (Lond) 109 (2005) 243-256
38. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
39. Mattacks C.A., and Pond C.M. Interactions of noradrenalin and tumour necrosis factor alpha, interleukin 4 and interleukin 6 in the control of lipolysis from adipocytes around lymph nodes. Cytokine 11 (1999) 334-346
40. Collart M.A., Baeuerle P., and Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10 (1990) 1498-1506
41. Kelley D.E., and Goodpaster B.H. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24 (2001) 933-941
42. Gregerman R.I. Aging and hormone-sensitive lipolysis: reconciling the literature. J Gerontol 49 (1994) B135-B139
43. Efendic S., and Portwood N. Overview of incretin hormones. Horm Metab Res 36 (2004) 742-746
44. Theodorakis M.J., Carlson O., Michopoulos S., et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290 (2006) E550-E559
45. Nauck M., Stockmann F., Ebert R., et al. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29 (1986) 46-52